Form 4: Repligen Corp Executive Sells Shares
SEC Form 4 Filing
Ralf Kuriyel, Senior VP of R&D at Repligen Corp, sold 4,465 shares of common stock on August 1, 2024, at a price of $165.67 per share.
Summary
- On August 1, 2024, Ralf Kuriyel, Senior VP of R&D at Repligen Corp, sold 4,465 shares of common stock.
- The transaction was executed at a price of $165.67 per share.
- Following the transaction, Kuriyel directly owns 19,261 shares of Repligen Corp common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock sale by an executive. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This is a routine disclosure of an insider transaction. It's common for executives to periodically sell shares for personal financial management.
Stakeholder Impact
- The sale of shares by a company executive could be perceived negatively by shareholders if they interpret it as a lack of confidence in the company's future performance, although this is a relatively small transaction.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date of the stock sale transaction |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.